Paragon Care Valuation

Is PGC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PGC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PGC (A$0.49) is trading above our estimate of fair value (A$0.43)

Significantly Below Fair Value: PGC is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PGC?

Key metric: As PGC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PGC. This is calculated by dividing PGC's market cap by their current earnings.
What is PGC's PE Ratio?
PE Ratio98.8x
EarningsAU$8.38m
Market CapAU$827.65m

Price to Earnings Ratio vs Peers

How does PGC's PE Ratio compare to its peers?

The above table shows the PE ratio for PGC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average49.1x
ACL Australian Clinical Labs
28.9x16.0%AU$692.4m
NAN Nanosonics
82.8x24.0%AU$1.1b
PSQ Pacific Smiles Group
38.7x16.3%AU$311.2m
HLA Healthia
46.1xn/aAU$252.1m
PGC Paragon Care
98.8x35.6%AU$827.7m

Price-To-Earnings vs Peers: PGC is expensive based on its Price-To-Earnings Ratio (98.8x) compared to the peer average (49.1x).


Price to Earnings Ratio vs Industry

How does PGC's PE Ratio compare vs other companies in the Global Healthcare Industry?

11 CompaniesPrice / EarningsEstimated GrowthMarket Cap
PGC 98.8xIndustry Avg. 20.6xNo. of Companies77PE01632486480+
11 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PGC is expensive based on its Price-To-Earnings Ratio (98.8x) compared to the Global Healthcare industry average (20.6x).


Price to Earnings Ratio vs Fair Ratio

What is PGC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PGC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio98.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PGC's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PGC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$0.48
AU$0.49
+1.0%
6.1%AU$0.52AU$0.46n/a2
Nov ’25AU$0.42
AU$0.49
+16.7%
6.1%AU$0.52AU$0.46n/a2
Oct ’25AU$0.46
AU$0.49
+6.5%
6.1%AU$0.52AU$0.46n/a2
Sep ’25AU$0.41
AU$0.49
+18.8%
6.1%AU$0.52AU$0.46n/a2

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies